Radiopharm Theranostics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions AUD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Radiopharm Theranostics Limited (RADX) - Annual data in billions AUD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun 2025Dec 2024Jun 2023Jun 2022Jun 2021
Current Assets
Cash and Cash Equivalents0.030.030.010.030.00
Cash & Short-Term Investments0.030.030.010.030.00
Accounts Receivable0.010.010.000.000.00
Inventory0.000.000.000.000.00
Other Current Assets0.000.000.000.000.00
Total Current Assets0.040.040.020.030.00
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Intangible Assets0.050.050.060.060.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.050.050.060.060.00
Total Assets0.090.090.070.080.00
Current Liabilities
Accounts Payable0.010.010.000.000.00
Accrued Liabilities0.000.000.000.000.00
Deferred Revenue0.000.000.000.000.00
Other Current Liabilities0.000.010.010.010.00
Total Current Liabilities0.010.010.010.010.00
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.00
Other Non-Current Liabilities0.030.030.020.010.00
Total Non-Current Liabilities0.030.030.020.010.00
Total Liabilities0.040.040.030.020.00
Stockholders' Equity
Common Stock0.180.180.100.090.00
Retained Earnings-0.15-0.15-0.07-0.030.00
Accumulated Other Comprehensive Income0.010.040.010.010.00
Minority Interest0.000.000.000.000.00
Shares Outstanding2.360.460.360.280.00
Total Stockholders' Equity0.040.040.050.060.00
Total Liabilities & Equity0.090.090.070.080.00